Dexmedetomidine, Ozone and Dexamethasone Local Injection in Carpal Tunnel Syndrome for Pain Relief
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-60
SponsorTanta University
About this trial
The aim of the present study is to compare the analgesic efficacy of Dexmedetomidine, Ozone and Dexamethasone regional injection in carpal tunnel syndrome.
Eligibility criteria
Qualifiers
Age from 20 to 60 years.
Both sexes.
Patients with ultrasonographic evidence of mild-to-moderate carpal tunnel syndrome (CTS).
Inclusion criteria will include numbness and pain in the median nerve (MN) distribution persisting for minimum of 3 months , nerve conduction studies (NCS) consistent with carpal tunnel syndrome (CTS) as per the American Association of Neuromuscular and Electro diagnostic Medicine (AANEM) guidelines, and an median nerve (MN) cross-sectional area (CSA)at the wrist >12 mm2 suggesting mild-to-moderate CTS forms.
Disqualifiers
Patient refusal.
Patients with severe symptoms and signs of CTS as identified per the American Association of Neuromuscular and Electro diagnostic Medicine (AANEM) guidelines,[14] as this is an indication for surgery,
Patients who show improvement on medical treatment,
Previous surgical or injectional CTS treatment,
Trial design
Treatments tested in this trial
- Dexmedetomidine
- Ozone
- Dexamethasone
Treatment groups
135 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov